Order now! - Pharmacist eLink
Order now! - Pharmacist eLink
Order now! - Pharmacist eLink
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Order</strong> <strong>now</strong>!<br />
Now available<br />
in 2 new strengths<br />
New 50-mg and 400-mg tablets<br />
• 50 mg for simpler dosing during initiation<br />
• 400 mg for an easier way to achieve higher doses †<br />
Strength<br />
Size<br />
Unit Dimensions<br />
NDC Height Width Depth<br />
SEROQUEL<br />
50 mg<br />
100 count 0310-0278-10 2.84" 1.62" 1.62"<br />
SEROQUEL<br />
50 mg<br />
100-count<br />
unit dose<br />
0310-0278-39 0.2" 4.5"<br />
2.8"<br />
SEROQUEL<br />
50 mg<br />
1000 count<br />
0310-0278-34<br />
4.26"<br />
2.03"<br />
2.03"<br />
50 mg<br />
1000 count<br />
50 mg<br />
100 count<br />
400 mg<br />
100 count<br />
SEROQUEL<br />
400 mg<br />
SEROQUEL<br />
400 mg<br />
100 count<br />
100-count<br />
unit dose<br />
0310-0279-10<br />
4.26"<br />
2.03"<br />
2.03"<br />
0310-0279-39 0.3" 4.5" 2.8"<br />
<strong>Order</strong> Now! <strong>Order</strong>s should be placed through your<br />
wholesaler. Please contact your wholesaler immediately<br />
for product price and available quantities.<br />
AstraZeneca has dedicated approximately 2500<br />
Professional Sales Specialists to promote the new<br />
50-mg and 400-mg tablets to various medical<br />
specialists nationwide.<br />
*All atypical prescriptions: Total prescriptions. Jan. 05-Dec. 05. New prescriptions.<br />
Sept. 04-Dec. 05. IMS Health. National Prescription Audit.<br />
†<br />
The safety of doses above 800 mg/day has not been evaluated in clinical trials.<br />
In the elderly and in patients with hepatic impairment, consideration should be<br />
given to a lower starting dose, a slower rate of dose titration, careful monitoring<br />
during the initial dosing period, and a lower target dose.<br />
For full Prescribing Information, please click here<br />
http://www.astrazeneca-us.com/pi/seroquel.pdf<br />
25 mg, 50 mg, 100 mg, 200 mg, 300 mg & 400 mg tablets<br />
*
<strong>Pharmacist</strong> counseling tips for patients<br />
• Take SEROQUEL as prescribed by your doctor<br />
• You should contact your doctor if you feel the need to stop treatment<br />
• Dizziness or lightheadedness can be a side effect of SEROQUEL<br />
• Be sure to drink plenty of water to avoid becoming dehydrated or overheated<br />
• Drowsiness can be a side effect of SEROQUEL, especially when you first start<br />
taking it. Do not drive or operate machinery if you feel drowsy<br />
• You should avoid becoming pregnant while taking SEROQUEL<br />
• You should not breast-feed while taking SEROQUEL<br />
• You should avoid consuming alcoholic beverages<br />
• You should inform your doctor of any other prescription or over-the-counter<br />
medicine you are taking or plan to take<br />
(Tablets shown are<br />
not actual size)<br />
Important Safety Information<br />
25 mg<br />
•SEROQUEL is indicated for the treatment of acute manic episodes associated with bipolar I disorder, as either monotherapy or adjunct therapy with<br />
lithium or divalproex, and the treatment of schizophrenia. Patients should be periodically reassessed to determine the need for continued treatment<br />
• Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk (1.6 to 1.7 times) of death<br />
compared to placebo (4.5% vs 2.6%, respectively). SEROQUEL is not approved for the treatment of patients with dementia-related psychosis<br />
•Prescribing should be consistent with the need to minimize the risk of tardive dyskinesia. A rare condition referred to as neuroleptic malignant<br />
syndrome has been reported with this class of medications, including SEROQUEL<br />
•Hyperglycemia, in some cases extreme and associated with ketoacidosis, hyperosmolar coma, or death, has been reported in patients treated<br />
with atypical antipsychotics, including SEROQUEL. Patients starting treatment with atypical antipsychotics who have or are at risk for diabetes<br />
should undergo fasting blood glucose testing at the beginning of and during treatment. Patients who develop symptoms of hyperglycemia should<br />
also undergo fasting blood glucose testing<br />
•Precautions include the risk of seizures, orthostatic hypotension, and cataract development<br />
•The most commonly observed adverse events associated with the use of SEROQUEL in clinical trials were somnolence, dry mouth, dizziness,<br />
constipation, asthenia, abdominal pain, postural hypotension, pharyngitis, SGPT increase, dyspepsia, and weight gain<br />
50 mg<br />
100 mg<br />
200 mg<br />
300 mg<br />
400 mg<br />
<strong>Pharmacist</strong> E-Link is an online communications network. <strong>Pharmacist</strong> E-Link is not an agent,<br />
employee or contractor of AstraZeneca Pharmaceuticals LP. Therefore, any reply to this e-mail will<br />
not be forwarded to AstraZeneca. Please contact AstraZeneca directly at 800.236.9933 with any<br />
questions or concerns you may have about their products.<br />
*All atypical prescriptions: Total prescriptions. Jan. 05-Jan. 06. New prescriptions. Sept. 04-Jan. 06.<br />
IMS Health. National Prescription Audit.<br />
*<br />
For full Prescribing Information, please click here<br />
http://www.astrazeneca-us.com/pi/seroquel.pdf<br />
AstraZeneca Pharmaceuticals LP<br />
25 mg, 50 mg, 100 mg, 200 mg, 300 mg & 400 mg tablets<br />
© 2006 AstraZeneca Pharmaceuticals LP. All rights reserved.<br />
SEROQUEL is a registered trademark of the AstraZeneca group of companies. 238165 3/06 www.SEROQUEL.com
Change language